Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      HUL expects to complete merger with GSK Consumer Healthcare in 2019

      HUL expects to complete merger with GSK Consumer Healthcare in 2019

      Medical Dialogues Bureau20 Jan 2019 9:45 AM IST
      "Once we get the court's approval, GSK Consumer India would merge into HUL. That process, we expected to take between 6 to 9 months because we require...
      Sandoz launches SYMJEPI epinephrine syringe in the US

      Sandoz launches SYMJEPI epinephrine syringe in the US

      Medical Dialogues Bureau20 Jan 2019 9:15 AM IST
      SYMJEPI will be rolled out through a phased launch, first in the institutional setting – an established channel where Sandoz Inc. has significant...
      Valeo Pharma and Zambon announces the approval of Onstryv for treatment of Parkinsons disease

      Valeo Pharma and Zambon announces the approval of Onstryv for treatment of Parkinsons disease

      Medical Dialogues Bureau20 Jan 2019 9:00 AM IST
      There is a growing need for new treatments to manage Parkinson’s Disease and Onstryv provides an important option for patients that require better...
      Aurobindo arm to acquire 7 oncology drug from Spectrum for $300 million

      Aurobindo arm to acquire 7 oncology drug from Spectrum for $300 million

      Medical Dialogues Bureau19 Jan 2019 9:45 AM IST
      The portfolio is expected to generate a revenue of around $100 million for the first 12 months after completion of the transaction for Aurobindo. The...
      Dr Reddy

      Dr Reddy's gets four observations from USFDA for Andhra plant

      Medical Dialogues Bureau19 Jan 2019 9:30 AM IST
      "The audit of our formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed today....
      Biomunex signs licensing agreement with Sanofi for development of antibodies

      Biomunex signs licensing agreement with Sanofi for development of antibodies

      Medical Dialogues Bureau19 Jan 2019 9:15 AM IST
      Under the terms of the agreement, Sanofi will have access to Biomunex proprietary technology to generate and optimize bi- and multi-specific antibody...
      Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

      Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

      Medical Dialogues Bureau17 Jan 2019 9:45 AM IST
      "We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just...
      Medtronic launches MyCareLink Heart mobile app to let patients monitor their pacemakers

      Medtronic launches MyCareLink Heart mobile app to let patients monitor their pacemakers

      Medical Dialogues Bureau17 Jan 2019 9:35 AM IST
      "The MyCareLink Heart mobile app is a technological game-changer for people with pacemakers," said James Allred, M.D., an electrophysiologist at Cone...
      OxyContin maker Purdue Pharma accused of deceiving patients and doctors

      OxyContin maker Purdue Pharma accused of deceiving patients and doctors

      Medical Dialogues Bureau17 Jan 2019 9:00 AM IST
      The documents add new details about former Purdue Pharma President Richard Sackler's role in overseeing sales of OxyContin.BOSTON - A member of the...
      Pfizer says USFDA accepts regulatory submissions for review of tafamidis

      Pfizer says USFDA accepts regulatory submissions for review of tafamidis

      Medical Dialogues Bureau16 Jan 2019 9:35 AM IST
      Pfizer has submitted two NDAs based on two forms of tafamidis: meglumine salt and free acid. Tafamidis is the only product to complete a Phase 3 trial...
      EMA revises guideline to strengthen global approach to develop antibacterial drugs

      EMA revises guideline to strengthen global approach to develop antibacterial drugs

      Medical Dialogues Bureau16 Jan 2019 9:00 AM IST
      EMA plays an important role in the fight against antimicrobial resistance by supporting the development of new medicines and treatment approaches,...
      Lupin recalls 5 lots of Ceftriaxone for Injection

      Lupin recalls 5 lots of Ceftriaxone for Injection

      Medical Dialogues Bureau15 Jan 2019 9:15 AM IST
      Ceftriaxone for Injection, USP, is used as a sterile, semi-synthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok